The setting
makes software and data services for cancer care and research. is its electronic medical record system for smaller practices in the community that treat cancer.
Keeping molecular orders live conflicts with certainty that each result belongs in the treatment plan.
Clinicians need an unambiguous review point before treatment, while practices need continuity for tests already ordered.
Who you’d be doing this for
“I have a result in the chart, but I cannot tell if it is the one my plan is relying on.”
Vincent Laurent · Community Oncologist · a character in this brief
Uses OncoEMR to connect genomic test results to treatment planning for patients receiving cancer care.
What is at stake
Community oncologists cannot always link a genomic result to the treatment plan in front of them. You must decide whether continuity for active orders outweighs pausing the workflow until the clinical review boundary is proven.
Why it isn’t already fixed
Every obvious fix costs something else. That’s the part you’d have to decide.
- ordering continuity vs clinical certainty
- rapid containment vs durable workflow trust
- practice consistency vs local care disruption
- release recovery vs defensible sign-off
Why Flatiron Health
OncoEMR sits inside the treatment planning and delivery workflow where community practices act on molecular test results.
Written with these in mind
Not your kind of problem? 2 more at Flatiron Health, or browse every organization.
Where the organization context comes fromThe postings this brief was written from, and the reporting read before it.
The organization context comes from public information. The situation and characters are written for the brief.
Job postings it was written from
Public descriptions of the work at Flatiron Health. They are listed as sources, not as openings. The lines under a posting are its own words, where it meets this brief.
- Product Manager (Clinical Workflows) (opens in a new tab)
- Ensuring all solutions adhere to strict safety, regulatory, and compliance standards while delivering an intuitive user experience for care teams.
- Leading the design, development, and rollout of data-driven products that streamline clinical operations, and reinforce safe, high-quality care delivery.
- Lead Product Manager (Clinical Workflows) (opens in a new tab)
- Flatiron’s HC Product teams are deeply cross-functional given their focus on creating end to end solutions clinicians rely on every day to deliver safe and efficient cancer care —from diagnosis and staging through treatment planning, ordering, and delivery.
- Leading your team in translating complex clinical context, technical constraints, and business goals into clear product requirements, making strategic tradeoffs at the portfolio level to deliver safe and delightful solutions.
- Clinical Genomics Advanced Practice Provider (opens in a new tab)
- The role is designed for an advanced practice provider (Nurse Practitioner or Physician Assistant) with deep experience in clinical oncology, genomic testing, test result interpretation, and subsequent patient care and clinical decisions.
- Develop and deliver educational resources (e.g., guides, presentations, webinars) to help practices utilize point of care genomic testing recommendations, orders, and results in support of personalized patient care.
Reporting read before this brief was written
The pieces closest to the situation in this brief.
Quest Diagnostics said on July 8, 2026 that it is integrating its Haystack MRD test and comprehensive genomic profiling into OncoEMR through the Molecular Profiling Integration ordering feature, with nearly 200 American Oncology Network sites able to order and a nationwide launch planned for the second half of the year.
Quest Adds Haystack MRD to Flatiron's OncoEMR Ordering (opens in a new tab) · apoapenews.com · Sep 16, 2026
This is the setup. The work is inside.
Running it puts you in the room: the full situation and its constraints, stakeholders who push back in their own words, and the decisions that are yours to make. What you produce becomes a Day One Plan — work you can show someone instead of describing.
Where similar work appears
Other live briefs connected to this one, and what connects them.
Similar problems at other organizations
Like this one, each of these turns on moving faster inside a system others depend on.
Several prescription orders show complete even though pharmacy staff cannot confirm patient handoff.
You have to weigh a growth commitment against evidence that is costly to verify and hard to reverse.
Eighteen pending software changes lack a documented filing-impact decision.
You must protect release speed without letting regulated health wording outrun its evidence.
Other problems with a similar purpose
In each of these, as in this one, the aim is to get the right piece of information into a decision-maker's hands at the precise moment it changes their choice.
The claims AI agent flagged 2,900 likely eligible denials, but its confidence varies across remittance histories.
You have to move verified payments quickly while preventing irreversible errors in the payer record.
Paid claims can briefly display a status that disagrees with the remittance record.
You must weigh fast provider updates against a claim history clinicians can trust.
Hospitalists are rebuilding routine progress-note context every day instead of returning to ambient drafts.
You must weigh faster daily documentation against a review flow that keeps old clinical facts from entering a new record.
